Emerge Health Patient Program

In March 2018, Kos designed, developed, and implemented the Emerge Health Patient Program. Emerge Health Pty Ltd partnered with PharmaPrograms to facilitate the streamlined dispensing of Sativex® Oromucosal Spray, nabiximols 80 mg/mL pump actuated metered dose aerosol (ARTG ID 181978) through community pharmacies.